-+ 0.00%
-+ 0.00%
-+ 0.00%

Jupiter Neurosciences Unveils Nugevia PWR To Meet Demand For Clinically Validated Longevity Supplements; Commercial Availability Expected In Fall 2025

Benzinga·06/30/2025 19:20:38
Listen to the news

PWR delivers science-driven cellular energy and recovery support as part of Jupiter's expanding longevity supplement portfolio

Jupiter, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, is pleased to unveil Nugevia™ PWR, a daily mitochondrial health supplement scientifically formulated to support cellular energy, endurance, and recovery. PWR targets a rapidly expanding consumer demand for science-backed, clinically validated supplements, providing a high-margin growth opportunity within the longevity and wellness markets, projected to reach $8 trillion by 2030, with commercial availability expected in Fall 2025.